相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration
Qinggong Yuan et al.
HEPATOLOGY (2013)
Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
Gang Chen et al.
BMC MEDICINE (2012)
Novel insights into the molecular mechanisms of alpha-fetoprotein expression and malignant phenotypes of hepatocellular carcinoma
Zhiqing Hu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2012)
MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma
Claudia Augello et al.
LIVER INTERNATIONAL (2012)
Morphometric analysis of hepatocellular nodular lesions in HCV cirrhosis
Maurizio Vertemati et al.
PATHOLOGY RESEARCH AND PRACTICE (2012)
microRNA Involvement in Hepatocellular Carcinoma
Massimo Negrini et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2011)
Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance
Jipeng Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Influence of RT-qPCR primer position on EGFR interference efficacy in lung cancer cells
Gang Chen et al.
BIOLOGICAL PROCEDURES ONLINE (2011)
miR-221 Silencing Blocks Hepatocellular Carcinoma and Promotes Survival
Jong-Kook Park et al.
CANCER RESEARCH (2011)
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
J. -L. Raoul et al.
CANCER TREATMENT REVIEWS (2011)
The Role of Oncogenic Viruses in the Pathogenesis of Hepatocellular Carcinoma
Romy Zemel et al.
CLINICS IN LIVER DISEASE (2011)
Molecular Pathogenesis of Hepatocellular Carcinoma: Altering Transforming Growth Factor-beta Signaling in Hepatocarcinogenesis
Ken Yamazaki et al.
DIGESTIVE DISEASES (2011)
MicroRNA-221 Regulates FAS-Induced Fulminant Liver Failure
Amar Deep Sharma et al.
HEPATOLOGY (2011)
Clinical significance of miR-221 and its inverse correlation with p27Kip1 in hepatocellular carcinoma
Xinhui Fu et al.
MOLECULAR BIOLOGY REPORTS (2011)
The functional role of long non-coding RNA in human carcinomas
Ewan A. Gibb et al.
MOLECULAR CANCER (2011)
Hepatocellular Carcinoma in 2011 and Beyond: From the Pathogenesis to Molecular Targeted Therapy Introduction
Masatoshi Kudo
ONCOLOGY (2011)
MicroRNA Profile Predicts Recurrence after Resection in Patients with Hepatocellular Carcinoma within the Milan Criteria
Fumiaki Sato et al.
PLOS ONE (2011)
The Molecular Pathogenesis and Clinical Implications of Hepatocellular Carcinoma
Makoto Meguro et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2011)
Quantification of epidermal growth factor receptor T790M mutant transcripts in lung cancer cells by real-time reverse transcriptase-quantitative polymerase chain reaction
Gang Chen et al.
ANALYTICAL BIOCHEMISTRY (2010)
miR-221/222 suppression protects against endoplasmic reticulum stress-induced apoptosis via p27Kip1- and MEK/ERK-mediated cell cycle regulation
Rongyang Dai et al.
BIOLOGICAL CHEMISTRY (2010)
TNM Seventh Edition: What's New, What's Changed Communication From the International Union Against Cancer and the American Joint Committee on Cancer
Leslie H. Sobin et al.
CANCER (2010)
MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
Richard Hummel et al.
EUROPEAN JOURNAL OF CANCER (2010)
Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma
Lang Hu et al.
HEPATOLOGY INTERNATIONAL (2010)
Serum microRNAs as non-invasive biomarkers for cancer
Jan C. Brase et al.
MOLECULAR CANCER (2010)
microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma
Julja Burchard et al.
MOLECULAR SYSTEMS BIOLOGY (2010)
miR-221 overexpression contributes to liver tumorigenesis
Pascal Pineau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma on Cirrhosis: State of the Art and Future Perspectives
Antonio Giorgio
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2010)
Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma
Shu Diao et al.
PROTEOMICS (2010)
MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL
Qiang Lu et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
Michela Garofalo et al.
CANCER CELL (2009)
MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality
Laura Gramantieri et al.
CLINICAL CANCER RESEARCH (2009)
MicroRNA-101 Regulates Expression of the v-fos FBJ Murine Osteosarcoma Viral Oncogene Homolog (FOS) Oncogene in Human Hepatocellular Carcinoma
Shuai Li et al.
HEPATOLOGY (2009)
Differential MicroRNA Expression Between Hepatitis B and Hepatitis C Leading Disease Progression to Hepatocellular Carcinoma
Shunsuke Ura et al.
HEPATOLOGY (2009)
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated
Xiao-Hui Huang et al.
HEPATOLOGY RESEARCH (2009)
Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma
Melanie B. Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study
Sandrine Faivre et al.
LANCET ONCOLOGY (2009)
Molecular Mechanisms Underlying Hepatocellular Carcinoma
Philippe Merle et al.
VIRUSES-BASEL (2009)
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen et al.
CELL RESEARCH (2008)
Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease
Noah T. Zinkin et al.
CLINICAL CANCER RESEARCH (2008)
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1
Queenie W. -L. Wong et al.
GASTROENTEROLOGY (2008)
Molecular Mechanisms of Hepatocellular Carcinoma
Rajagopal N. Aravalli et al.
HEPATOLOGY (2008)
Profiling MicroRNA expression in hepatocellular carcinoma reveals MicroRNA-224 up-regulation and apoptosis inhibitor-5 as a MicroRNA-224-specific target
Yu Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
MicroRNA involvement in hepatocellular carcinoma
Laura Gramantieri et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Design and endpoints of clinical trials in hepatocellular carcinoma
Josep M. Llovet et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Sorafenib in Advanced Hepatocellular Carcinoma
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma
F. Fornari et al.
ONCOGENE (2008)
Expression of heparanase in hepatocellular carcinoma has prognostic significance: A tissue microarray study
Gang Chen et al.
ONCOLOGY RESEARCH (2008)
MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma
Heike Varnholt et al.
HEPATOLOGY (2008)
Cyclin g1 is a target of miR-122a, a MicroRNA frequently down-regulated in human hepatocellular carcinoma
Laura Gramantieri et al.
CANCER RESEARCH (2007)
Molecular mechanisms of the chemopreventive effect on hepatocellular carcinoma development in Mdr2 knockout mice
Mark Katzenellenbogen et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma
AX Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues
Y Murakami et al.
ONCOGENE (2006)
Phase II study of erlotinib (OSI-774) in patients with advanced hepatocellular cancer
PA Philip et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Estimating the world cancer burden: GLOBOCAN 2000
DM Parkin et al.
INTERNATIONAL JOURNAL OF CANCER (2001)